Status: Recruiting
A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma
By comparing the diagnostic accuracy of spectral CT and conventional CT in evaluating treatment response efficacy after TACE, this study aims to investigate the diagnostic performance of spectral CT in assessing treatment response following TACE for hepatocellular carcinoma.
Participants needed: 121
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Zhongda HospitalUpdated: Jun 10, 2026Locations: 1Duration: 1 Year
Eligibility criteria
age 18-75 years; [+6]
contraindications to contrast-enhanced CT or MRI; [+4]